ImmunoGenesis

Houston, United States

ImmunoGenesis specializes in science-driven immune therapies for tumor treatment.

$5.7M raised

Jan 2025

Venture - Series Unknown

Biotechnology Health Care Health Diagnostics Life Science Medical

Top Investors

Cancer Prevention and Research Institute of Texas Cancer Focus Fund Texas HALO Fund Juno Capital

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about ImmunoGenesis

How much funding has ImmunoGenesis raised?

ImmunoGenesis has raised $5.7M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in January 2025.

Who are ImmunoGenesis's investors?

ImmunoGenesis's investors include Cancer Prevention and Research Institute of Texas, Cancer Focus Fund, Texas HALO Fund, Juno Capital.

Where is ImmunoGenesis headquartered?

ImmunoGenesis is headquartered in Houston, United States.

What does ImmunoGenesis do?

ImmunoGenesis specializes in science-driven immune therapies for tumor treatment.

What stage is ImmunoGenesis at?

ImmunoGenesis is at the Venture - Series Unknown stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated January 15, 2025.

MLA

"ImmunoGenesis — Funding & Investors." VCBacked, January 15, 2025, https://www.vcbacked.co/company/immunogenesis. Accessed July 2, 2026.

APA

VCBacked. (2025). ImmunoGenesis — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/immunogenesis

Wikipedia (cite web)

{{cite web |title=ImmunoGenesis — Funding & Investors |url=https://www.vcbacked.co/company/immunogenesis |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated January 15, 2025.

Similar Companies in Biotechnology

View all

Rapport Therapeutics

Boston$250.0M

Renaissance BioScience

Vancouver$599K

Allterum Therapeutics

Advanced Microbiome Interventions

Amsterdam$300K